Cargando…

Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study

BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohrs, Oliver K, Wunderlich, Nina, Petersen, Steffen E, Pottmeyer, Anselm, Kauczor, Hans-Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146401/
https://www.ncbi.nlm.nih.gov/pubmed/21726450
http://dx.doi.org/10.1186/1532-429X-13-33
_version_ 1782209200816914432
author Mohrs, Oliver K
Wunderlich, Nina
Petersen, Steffen E
Pottmeyer, Anselm
Kauczor, Hans-Ulrich
author_facet Mohrs, Oliver K
Wunderlich, Nina
Petersen, Steffen E
Pottmeyer, Anselm
Kauczor, Hans-Ulrich
author_sort Mohrs, Oliver K
collection PubMed
description BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4 PLAATO; n = 2 Watchman; n = 1 ACP) underwent 2 contrast-enhanced (Gd-DOTA) CMR sequences (2D TrueFISP first-pass perfusion and 3D-TurboFLASH) to assess localization, artifact size and potential leaks of the devices. Perfusion CMR was analyzed visually and semi-quantitatively to identify potential leaks. RESULTS: All occluders were positioned within the LAA. The ACP occluder presented the most extensive artifact size. Visual assessment revealed a residual perfusion of the LAA apex in 4 cases using first-pass perfusion and 3D-TurboFLASH indicating a suboptimal LAA occlusion. By assessing signal-to-time-curves the cases with a visually detected leak showed a 9-fold higher signal-peak in the LAA apex (567 ± 120% increase from baseline signal) than those without a leak (61 ± 22%; p < 0.03). In contrast, the signal increase in LAA proximal to the occluder showed no difference (leak 481 ± 201% vs. no leak 478 ± 125%; p = 0.48). CONCLUSION: This CMR pilot study provides valuable non-invasive information in patients after transcatheter occlusion of the LAA to identify correct placement and potential leaks. We recommend incorporating CMR in future clinical studies to evaluate new device types.
format Online
Article
Text
id pubmed-3146401
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31464012011-07-30 Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study Mohrs, Oliver K Wunderlich, Nina Petersen, Steffen E Pottmeyer, Anselm Kauczor, Hans-Ulrich J Cardiovasc Magn Reson Research BACKGROUND: To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks. METHODS: 7 patients with different occluder systems (n = 4 PLAATO; n = 2 Watchman; n = 1 ACP) underwent 2 contrast-enhanced (Gd-DOTA) CMR sequences (2D TrueFISP first-pass perfusion and 3D-TurboFLASH) to assess localization, artifact size and potential leaks of the devices. Perfusion CMR was analyzed visually and semi-quantitatively to identify potential leaks. RESULTS: All occluders were positioned within the LAA. The ACP occluder presented the most extensive artifact size. Visual assessment revealed a residual perfusion of the LAA apex in 4 cases using first-pass perfusion and 3D-TurboFLASH indicating a suboptimal LAA occlusion. By assessing signal-to-time-curves the cases with a visually detected leak showed a 9-fold higher signal-peak in the LAA apex (567 ± 120% increase from baseline signal) than those without a leak (61 ± 22%; p < 0.03). In contrast, the signal increase in LAA proximal to the occluder showed no difference (leak 481 ± 201% vs. no leak 478 ± 125%; p = 0.48). CONCLUSION: This CMR pilot study provides valuable non-invasive information in patients after transcatheter occlusion of the LAA to identify correct placement and potential leaks. We recommend incorporating CMR in future clinical studies to evaluate new device types. BioMed Central 2011-07-04 /pmc/articles/PMC3146401/ /pubmed/21726450 http://dx.doi.org/10.1186/1532-429X-13-33 Text en Copyright ©2011 Mohrs et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mohrs, Oliver K
Wunderlich, Nina
Petersen, Steffen E
Pottmeyer, Anselm
Kauczor, Hans-Ulrich
Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
title Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
title_full Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
title_fullStr Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
title_full_unstemmed Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
title_short Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
title_sort contrast-enhanced cmr in patients after percutaneous closure of the left atrial appendage: a pilot study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146401/
https://www.ncbi.nlm.nih.gov/pubmed/21726450
http://dx.doi.org/10.1186/1532-429X-13-33
work_keys_str_mv AT mohrsoliverk contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy
AT wunderlichnina contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy
AT petersensteffene contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy
AT pottmeyeranselm contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy
AT kauczorhansulrich contrastenhancedcmrinpatientsafterpercutaneousclosureoftheleftatrialappendageapilotstudy